Determination of domperidone in human plasma using high performance liquid chromatography with fluorescence detection for clinical application

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 961, Issue , 2014, Pages 86-90

  Yoshizato, Tsuneaki ^a   Tsutsumi, Kimiko ^a   Kotegawa, Tsutomu ^a   Imai, Hiromitsu ^a   Nakano, Shigeyuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Domperidone; Fluorescence detection; HPLC; Itraconazole; MDR1; Solid phase extraction

Indexed keywords

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHASE SEPARATION;

DOMPERIDONE; FLUORESCENCE DETECTION; HPLC; ITRACONAZOLE; MDR1; SOLID-PHASE EXTRACTION;

PLASMA (HUMAN);

DOMPERIDONE; ITRACONAZOLE;

ADULT; BLOOD; CONTROLLED STUDY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MALE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SOLID PHASE EXTRACTION;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOMPERIDONE; FLUORESCENCE; HUMANS; ITRACONAZOLE; LIMIT OF DETECTION; MALE; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION;

EID: 84901320354     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2014.05.004     Document Type: Article

References (19)

1. Reddymasu S.C., Soykan I., McCallum R.W. Am. J. Gastroenterol. 2007, 102:2036.
2. Heykants J., Hendriks R., Meuldermans W., Michiels M., Scheygrond H., Reyntjens H. Eur. J. Drug Metab. Pharmacokinet. 1981, 6:61.
3. Ward B.A., Morocho A., Kandil A., Galinsky R.E., Flockhart D.A., Desta Z. Br. J. Clin. Pharmacol. 2004, 58:277.
4. El Ela A.A., Hartter S., Schmitt U., Hiemke C., Spahn-Langguth H., Langguth P. J. Pharm. Pharmacol. 2004, 56:967.
5. Masaoka T., Tack J. Gut Liver 2009, 3:166.
6. Li Z., Yao J., Zhang Z., Zhang L. J. Chromatogr. Sci. 2009, 47:881.
7. Xu D.-H., Lou H.-G., Yuan H., Jiang B., Zhou Q., Zhang Z.-M., Ruan Z.-R. Biomed. Chromatogr. 2008, 22:433.
8. Zavitsanos A.P., MacDonald C., Bassoo E., Gopaul D. J. Chromatogr. B 1999, 730:9.
9. Kobyllińska M., Kobylińska K. J. Chromatogr. B 2000, 744:207.
10. Smit M.J., Sutherland F.C.W., Hundt H.K.L., Swart K.J., Hundt A.F., Els J. J. Chromatogr. A 2002, 949:65.
11. Michaud V., Simard C., Turgeon J. J. Chromatogr. B 2007, 852:611.
12. Yamamoto K., Hagino M., Kotaki H., Iga T. J. Chromatogr. B 1998, 720:251.
13. F.D.A. Guidance for industry: Biomedical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation (CDER) and Research & Center for Veterinary Medicine (CVM) (2001). http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.
14. Sakaeda T., Nakamura T., Horinouchi M., Kakumoto M., Ohmoto N., Sakai T., Morita Y., Tamura T., Aoyama N., Hirai M., Kasuga M., Okumura K. Pharm. Res. 2001, 18:1400.
15. Imanaga J., Kotegawa T., Imai H., Tsutsumi K., Yoshizato T., Ohyama T., Shirasaka Y., Tamai I., Tateishi T., Ohashi K. Pharmacogenet. Genom. 2011, 32:84.
16. Itohda A., Tsutsmi K., Imai H., Iwao M., Kotegawa T., Ohashi K. J. Chromatogr. B 2012, 904:88.
17. Boyce M.J., Baisley K.J., Warrington S.J. Br. J. Clin. Pharmacol. 2012, 73:411.
18. Pal D., Mitra A.K. J. Neuroimmune Pharmacol. 2006, 1:323.
19. Shoh J.-H., Yoon Y.-R., Hong W.-S., nguyen P.-M., Lee S.-S., Choi Y.-G., Cha I.-J., Shin J.-G. Clin. Pharmacol. Ther. 2005, 78:191.